3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
127
Precursor Cell Lymphoblastic Leukemia-Lymphoma
46
Burkitt Lymphoma
26
Myelodysplastic Syndromes
25
Leukemia
25
Leukemia, Biphenotypic, Acute
21
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
15
Lymphoma, Mantle-Cell
14
Recurrence
13
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
10
Myeloproliferative Disorders
9
Lymphoma
9
Lymphoma, Non-Hodgkin
8
Leukemia, Myelomonocytic, Chronic
8
Lymphoma, Large B-Cell, Diffuse
7
Down Syndrome
6
Neoplasm, Residual
5
Hodgkin Disease
5
Blast Crisis
5
Sarcoma, Myeloid
4
Lymphoma, T-Cell
4
Leukemia, Monocytic, Acute
4
Hematologic Neoplasms
4
Lymphoma, Follicular
3
Leukemia, Myelomonocytic, Juvenile
3
Leukemia, Myelomonocytic, Acute
3
Leukemia, Myeloid, Accelerated Phase
3
Neoplasms
2
Multiple Myeloma
2
Lymphoma, B-Cell
2
Interventions
Arsenic Trioxide
6
Tretinoin
5
venetoclax
1
arsenous acid
1
Mitoxantrone
1
Methotrexate
1
Mercaptopurine
1
Magnetic Resonance Spectroscopy
1
Lisaftoclax
1
Idarubicin
1
Gemtuzumab
1
Gadolinium
1
Fluorodeoxyglucose F18
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, Promyelocytic, Acute
×
Cytarabine
×
1 year
×
Clear all
NCT02688140
2026-05-29
TUD-APOLLO-064
Technische Universität Dresden
Phase 3
Completed
133 enrolled